Tubulis Technologies

Developer of antibody-drug conjugates for the treatment of cancer

placeMunich, Bavaria, Germany calendar_todayFounded 2015 groups33 employees language tubulis.com

Registered entities

Social engagement

Social engagement: 17.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

29 investors on record; lead investors include Nextech Invest, Andera Partners, BioMedPartners, HTGF.

Investor typeCountShare
Venture capital1241%
Private equity517%
Accelerator & incubator310%
Other / undisclosed931%

Recent activity

21 Apr 2026
Event
ASCO26 Annual Meeting
9 Apr 2026
Event
TFmed2026
26 Mar 2026
Recognition
Coming soon